SCHEMBL19904433

SCHEMBL19904433

O=C(NC(Cc1ccc(OCC(F)(F)F)nc1)CN1CCCC1)[C@@H]1CCN(c2ccc(F)cc2)C1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.42
DEGS1 O15121 2/20 0.41
NOTUM Q6P988 2/20 0.40
CHRM4 P08173 5/20 0.39
HTR1A P08908 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
EPHX2 P34913 1/20 0.38
CYP2J2 P51589 1/20 0.38
SCN9A Q15858 1/20 0.36
ACACB O00763 1/20 0.36
KCNH2 Q12809 1/20 0.35
MCHR1 Q99705 1/20 0.35
SSTR1 P30872 1/20 0.35
SSTR3 P32745 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LIPE Q05469 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904665 0.93 HTR1A (0.41) GPR119NOTUMCHRM4HTR1A
SCHEMBL19904546 0.88 ACACB (0.43) DEGS1NOTUMCHRM4ACACBSSTR1
SCHEMBL19904492 0.88 ACACB (0.43) DEGS1NOTUMCHRM4ACACBSSTR1
SCHEMBL16695288 0.84 UGCG (0.44) GPR119DEGS1NOTUMCHRM4CYP2C9
SCHEMBL18094837 0.84 UGCG (0.44) GPR119DEGS1NOTUMCHRM4CYP2C9
SCHEMBL29605118 0.84 UGCG (0.44) GPR119DEGS1NOTUMCHRM4CYP2C9
SCHEMBL29605212 0.84 UGCG (0.44) GPR119DEGS1NOTUMCHRM4CYP2C9
SCHEMBL16695348 0.84 UGCG (0.44) GPR119DEGS1NOTUMCHRM4CYP2C9
SCHEMBL19904460 0.81 ACACB (0.41) NOTUMCHRM4HTR1AACACB
SCHEMBL19904658 0.81 ACACB (0.41) NOTUMCHRM4HTR1AACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed